acexamic acid

Known as: N-acetylamino-6-hexanoic acid, 6-(acetylamino)hexanoic acid, Hexanoic acid, 6-(acetylamino)- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2008
012319722008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
A 66-year-old woman, with stasis dermatitis, hypertension, and hypercholesterolemia, but no previous story of atopy, has been… (More)
  • table 1
Is this relevant?
1991
1991
A Phase I clinical trial and pharmacological study of nasogastrically administered hexamethylene bisacetamide, a polar-planar… (More)
Is this relevant?
1990
1990
Hexamethylene bisacetamide (HMBA) is converted by successive deacetylation and oxidation reactions to four major metabolites; in… (More)
Is this relevant?
1989
1989
6-Acetamidohexanal has been identified in human plasma and urine as a metabolite of the cell-differentiating agent, hexamethylene… (More)
Is this relevant?
1988
1988
We studied the ability of five metabolites of hexamethylene bisacetamide (HMBA), which we had previously identified in patient… (More)
  • figure 1
  • table 1
  • table 5
  • table 3
  • table 4
Is this relevant?
1988
1988
We have previously demonstrated a number of metabolites of hexamethylene bisacetamide (HMBA) in the urine of patients treated… (More)
Is this relevant?
1988
1988
We investigated whether leukemic cell lines could convert hexamethylene bisacetamide (HMBA) to any of the metabolites previously… (More)
  • figure 1
  • table 2
  • table 3
Is this relevant?
1987
1987
In order to further understand the clinical toxicities of hexamethylene bisacetamide (HMBA) and to allow appropriate in vitro… (More)
Is this relevant?
1986
1986
Hexamethylene bisacetamide, a compound which in vitro induces differentiation in a wide variety of human and animal cancer cell… (More)
  • table 3
  • figure 2
Is this relevant?
1979
1979
Acexamic acid is currently used to avoid pulmonary fibrosis in patients treated with bleomycim. It seems to be equally effective… (More)
Is this relevant?